Position Statement on Anti-Dementia Medication for Alzheimer’s Disease by Swiss Stakeholders

oleh: Giovanni B Frisoni, Jean-Marie Annoni, Stefanie Becker, Tim Brockmann, Markus Buerge, Jean-François Démonet, Dan Georgescu, Anton Gietl, Ulrich Hemmeter, Stefan Klöppel, Thomas Leyhe, Andreas U Monsch, Franco Rogantini, Delphine Roulet Schwab, Egemen Savaskan, Karl Schaller, Armin von Gunten, Gabriel Gold

Format: Article
Diterbitkan: MDPI AG 2021-08-01

Deskripsi

The present document represents the position of Swiss health-care associations, clinical and research centers, research-supporting foundations, and the association Alzheimer Switzerland regarding the care of persons with dementia and Alzheimer’s disease. We claim that dementia is not part of normal aging but a disease developing more frequently in old age; early diagnosis and treatment of dementia is paramount; all patients with dementia have the right to receive state-of-the-art treatments; more intense information, education, and counseling on dementia are necessary; media should provide balanced and fair reporting of scientific discoveries on Alzheimer’s and dementia; all patients with dementia have the right to be treated; anti-dementia drugs should be used and accompanied by listening, compassion, and understanding.